Is UniQure (QURE) One of the Promising Stocks to Buy Under $50? [Yahoo! Finance]
uniQure N.V. - Ordinary Shares (QURE)
Last uniqure n.v. - ordinary shares earnings: 4/29 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
uniqure.com/investors-newsroom/overview.php
Company Research
Source: Yahoo! Finance
In its 2026 biotech sector outlook, Stifel conducted a comprehensive review of its coverage universe. This refreshed diligence resulted in several adjustments to financial models, earnings estimates, and price targets across the group. Mizuho analyst Uy Ear also reduced the price target for UniQure (NASDAQ:QURE) to $33 from $60 earlier on December 8, while maintaining an Outperform rating on the shares. This adjustment followed a major regulatory shift: the FDA informed the company that current data from its Phase I/II studies for AMT-130 (a Huntington's disease gene therapy) likely lacks the primary evidence required for a BLA. Consequently, Mizuho lowered its projected probability of success and delayed the expected market launch of AMT-130 by one year. Despite these hurdles, the firm remained optimistic about the therapy's long-term potential, noting that a follow-up Type A meeting with the FDA is scheduled for Q1 2026 to establish a new path forward. UniQure (NASDAQ:QURE) de
Show less
Read more
Impact Snapshot
Event Time:
QURE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QURE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QURE alerts
High impacting uniQure N.V. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
QURE
News
- uniQure (NASDAQ:QURE) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.MarketBeat
- QURE Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the FirmGlobeNewswire
- uniQure (NASDAQ:QURE) was downgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=QURE&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> MarketBeat
- uniQure Announces Type A Meeting Scheduled with FDAGlobeNewswire
- QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the FirmPR Newswire
QURE
Earnings
- 11/10/25 - Miss
QURE
Sec Filings
- 1/14/26 - Form 4
- 1/13/26 - Form 8-K
- 1/12/26 - Form 4
- QURE's page on the SEC website